Nephrosant

About:

NephroSant’s mission is to deliver new diagnostic tools for early detection and lifetime monitoring of kidney health and injury.

Website: https://nephrosant.com/

Twitter/X: nephrosant

Top Investors: DigitalDx Ventures, DaVita Venture Group

Description:

NephroSant is a fast-paced diagnostic startup founded by physicians, with a team of world-class scientists, engineers and clinicians, focused on applying the founding team's years of clinical research expertise to improve global kidney health.

Total Funding Amount:

$16M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Brisbane, California, United States

Founded Date:

2017-01-01

Founders:

Joshua Yang, Minnie Sarwal

Number of Employees:

11-50

Last Funding Date:

2021-03-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai